Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 6, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

New perspectives on effector mechanisms in uveitis.

Dror Luger1, Rachel R Caspi

  • 1Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Drive, Building 10, Room 10N222, Bethesda, MD 20892, USA.

Seminars in Immunopathology
|March 5, 2008
PubMed
Summary

Experimental autoimmune uveitis (EAU) is induced by different T cell types, including CD4+ Th1, CD8+ T cells, and IL-17-producing Th17 cells. The dominant T cell type depends on initial antigen exposure, explaining disease heterogeneity and informing treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IAN, an intelligent system for omics data analysis and discovery.

Cell reports methods·2026
Same author

Quantitative imaging for assessing uveitis activity: A comprehensive review.

Survey of ophthalmology·2026
Same author

Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Commensal-derived trehalose monocorynomycolate triggers γδ T cell-driven protective ocular barrier immunity.

Immunity·2026
Same author

Gut microbial interaction networks control autoimmunity to neuroretina.

bioRxiv : the preprint server for biology·2026
Same author

TLR2 supports γδ T cell IL-17A response to ocular surface commensals by metabolic reprogramming.

The Journal of experimental medicine·2025

Area of Science:

  • Immunology
  • Ophthalmology
  • Autoimmunity

Background:

  • Experimental autoimmune uveitis (EAU) models human autoimmune uveitis, providing insights into disease mechanisms.
  • Uveitis can be induced by CD4+ Th1 cells and CD8+ T cells; antibodies play a secondary role.
  • The role of interleukin-17 (IL-17)-producing T helper 17 (Th17) cells in uveitis is under active investigation.

Purpose of the Study:

  • To investigate the role of Th17 cells in EAU induction and pathogenesis.
  • To understand the factors determining the dominance of Th17 versus Th1 cells in EAU.
  • To elucidate the heterogeneity of autoimmune uveitis based on effector T cell populations.

Main Methods:

  • Induction of EAU in animal models.
  • Analysis of T cell populations (Th1, Th8, Th17) in the eye and lymphoid organs.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Related Experiment Videos

Last Updated: Jul 6, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

  • Assessment of disease severity and clinical manifestations.
  • Investigation of the impact of self-antigen exposure conditions on T cell differentiation.

    • Main Results:

    • Th17 cells are capable of inducing EAU and are found in affected eyes.
    • Both Th17 and Th1 cells can be dominant effector cells in different EAU models.
    • The conditions of initial self-antigen exposure influence whether Th1 or Th17 cells dominate.
    • Antibody production appears to be a secondary event after blood-retinal barrier disruption.

    Conclusions:

    • Autoimmune uveitis exhibits heterogeneity driven by distinct effector T cell populations, primarily Th1 and Th17 cells.
    • The type of initial antigen exposure dictates the dominant T cell response, influencing disease phenotype.
    • Understanding these effector mechanisms is crucial for developing targeted and effective treatment strategies for human uveitis.